BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Gradalis Inc. 

2545 Golden Bear Drive
Suite 110
Carrollton  Texas  75006  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS




Industry
Biotechnology






 Company News
Gradalis Inc. Announces Presentation Of New Data 6/18/2014 9:09:41 AM
Gradalis Inc. Announces Dr. Scott Gottlieb Joins Board Of Directors 6/4/2014 9:03:30 AM
Gradalis Inc. Announces Appointment of Phillip B. Maples, Ph.D., as Executive Vice President and Chief Technical Officer 8/20/2013 6:14:41 AM
Ex-Prometheus Exec Tapped to Lead Gradalis Inc. 7/23/2013 6:37:53 AM
Gradalis Inc. Release: FANG™ Personalized Tumor Vaccine Stimulates Immune Response and More than Doubles Time to Recurrence in Patients with Advanced Stage Ovarian Cancer 5/16/2013 9:27:33 AM
Gradalis Inc. Closes $24 Million in Series B Financing 1/3/2013 7:25:50 AM
Baylor College of Medicine and Gradalis Inc. Enter Collaboration Agreement to Utilize Gradalis' Bifunctional shRNA Platform in Translational Medicine Research 7/11/2012 10:13:27 AM
Gradalis Inc. Release: Study Published in Molecular Therapy Shows that Immune Response to FANG(TM) Personalized Cancer Therapeutic Correlates with Prolonged Survival in Patients with Advanced Stage Cancer 3/1/2012 10:37:27 AM
Champions Biotechnology, Inc. (CSBR) Partners with Gradalis Inc. and Mary Crowley Cancer Research Center to Develop Personalized Vaccines for Cancer Patients 2/3/2009 9:37:01 AM